Sickle Cell Disease and Stroke: Primary Prevention and Transcranial Doppler

Annals of Neurology

Volumn 54, Issue 5, 2003, Pages 559-563

  Adams, Robert J ^a   Pavlakis, Steve ^b   Roach, E Steve ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MAIMONIDES MEDICAL CENTER   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYUREA; WARFARIN;

AGE DISTRIBUTION; ARTERY DISEASE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; EDITORIAL; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MOYAMOYA DISEASE; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRACTICE GUIDELINE; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SCREENING; SECONDARY PREVENTION; SICKLE CELL ANEMIA; STROKE; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES; VASCULAR DISEASE;

ANEMIA, SICKLE CELL; CEREBROVASCULAR ACCIDENT; CHILD; HUMANS; RANDOMIZED CONTROLLED TRIALS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 0242290079     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10776     Document Type: Editorial

References (31)

1. Steen et al. Brain injury in children with sickle cell disease: prevalence and etilogy. Ann Neurol 2003;54:564-572.
2. Moser FG, Miller ST, Bello JA, Pegelow CH, Zimmerman RA, Wang WC, Frempong KO, Schwartz A, Vichinsky EP, Gallagher D, Kinney TR. The spectrum of brain MR abnormalities in sickle cell disease: A report from the cooperative study of sickle cell disease. American J of Neuro Radiology 1996;17:965-972.
3. Pavlakis SG. Neurologic complications of sickle cell disease. Adv Pediatr 1989;36:247-76.
4. Clinical Alert from the National Heart, Lung, and Blood Institute. Dept. of Health & Human Services, 18 Sept 1997.
5. Adams RJ, Brambilla DJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Woods G, Olivieri N, Driscoll C, Miller S, Wang W, Hurlet A, Scher C, Berman B, Carl EM, Nichols FT, Roach S, Kurlar A, Wright E, Zimmerman RA, Gallagher D, Waclawiw M, Bonds D. Transfusion Prevents First Stroke in Children with Sickle Cell Disease: The "STOP" Study. N Engl J Med July 1998;339(1):5-11.
6. Lane P, Buchanan GR, Ware RE. Variable approaches to therapeutic options for children with sickle cell disease (SCD): a practice survey of the American Society of Pediatric Hematology/Oncology (ASPHO). Blood 2001;98:784a.
7. American Academy of Pediatrics, Section on Hematology/Oncology and Committee on Genetics. Health supervision for children with sickle cell disease. Pediatrics 2002;109:526-535.
8. Adams RJ, McKie VC, Carl EM, Nichols FT, Perry R, Brock K, McKie K, Figueroa R, Litaker M, Weiner S, Brambilla D. Long term stroke risk in children with sickle cell disease screened with transcranial doppler. Annals of Neurology. 1997;42(5):699-704.
9. José Biller, MD, Chair; William M. Feinberg, MD; John E. Castaldo, MD; Anthony D. Whittemore, MD; Robert E. Harbaugh, MD; Robert J. Dempsey, MD; Louis R. Caplan, MD; Timothy F. Kresowik, MD; David B. Matchar, MD; James F. Toole, MD; J. Donald Easton, MD; Harold P. Adams, Jr, MD; Lawrence M. Brass, MD; Robert W. Hobson, II, MD; Thomas G. Brott, MD; Linda Sternau, MD. Guidelines for Carotid Endarterectomy. Stroke. 1998 Feb;29(2):554-62,
10. Caro JJ, Miglianccio-Walle K. Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. CAPRA (CAPRIE Actual Practe Rates Analysis) Study Group. Am J Med 1999;107(6):568-572.
11. Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood 1993;81(5):1109-1123.
12. Adams RJ, McKie VC, Nichols FT, Carl EM, Zhang DL, McKie K, Figueroa R, Litaker M, Thompson W, Hess DC. The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease. NEJM April 1992;326(9):605-610.
13. Pegelow CH, Wang W, Granger S, Hsu LL, Vichinsky E, Moser FG, Bello J, Zimmerman R, Adams RJ, Brambilla D. Silent Infarcts in Children with Sickle Cell Anemia and Abnormal Cerebral Artery Velocity. Arch Neurol 2001;58:2017-2021.
14. Abboud M, Cure J, Gallagher D, Hsu L, Wang W, Zimmerman R, Brambilla D, Lewin J, Adams RJ. Magnetic Resonance Angiography (MRA) in Children with Abnormal Transcranial Doppler (TCD) Velocities in the STOP Study. Blood, 1999;94(10)(Suppl. 1):645a.
15. Adarns RJ, Brambilla D, McKie VC, Files B, Vichinsky E, Abboud M, Hsu L, Pegelow C, Woods G, Miller S, Wang W, Olivieri N, Berman B, Hurlet A, Piomelli S, Driscoll C, Scher C, Adamkiewicz T, Wright E, Zimmerman R, Carl EM, Nichols FT, Kutlar A, Roach ES, Granger S, Jones AJ, Gallagher D. Stroke Prevention in Sickle Cell Disease (STOP): Final Results. Blood 2000;96:10a.
16. Paciarione M, Eliasziw M, Sharpe B, Kappelle J, Chaturvedi S, Meldrum H, Barnett HJM. Long-term Clinical and Angiographic Outcomes in Symptomatic Patients with 70%-00% Artery Stenosis. Stroke 2000;31:2037-2042.
17. Nichols FT, Jones AM, Adams RJ. Stroke Prevention in Sickle Cell Disease (STOP) Study Guidelines for Transcranial Doppler Testing. J Neuroimaging 2001;11:354-362.
18. Jones AM, Seibert JJ, Nichols FT, Kinder DL, Cox K, Luden J, Carl EM, Brambilla DJ, Saccente S, Adams RJ. Comparison of Transcranial Color Doppler Imaging (TCDI) and Transcranial Doppler (TCD) in Children with Sickle Cell Anemia. Pediat Radiol 2001;31:461-469.
19. Bulas DI, Jones A, Siebert JJ, Driscoll C, O'Donnell R, Adams RJ. Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatr Radiol 2000;30:733-738.
20. Neish A, Blews DE, Sims CA, Merritt RK, Spinks AJ. Screening for stroke in sickle cell anemia: comparison of transcranial Doppler imaging and nonimaging US techniques. Radiology 2002;222(3):709-714.
21. Russell MO, Goldberg HI, Hodson A, Kim HW, Halus J, Schwartz E. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 1984:162-169.
22. Frempong KO, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998;91(1):288-94.
23. Powers D, Adams RJ, Nichols FT, Milner P, Charache S, Sarniak S. Delayed intracranial hemorrhage following cerebral infarction in sickle cell anemia. JAAMP. 1990;1:79-82.
24. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-1322.
25. Ware RE, Zimmerman SA, Schultz WH. Hydroxyurea as an Alternative to Blood Transfusions for the Prevention of Recurrent Stroke in Children with Sickle Cell Disease. Blood 1999;94(9):3022-3026.
26. Walters MC, Storb R, Patience M, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood. 2000;95:1918-24.
27. http://www.nhlbi/nih.gov/health/public/blood/sickle.
28. Adams RJ, Brambilla D, Vichinsky E, Abboud M, Pegelow C, Carl EM, Nichols FT, Jones A, Luden J, Bowman L, Roach RS, Gallagher D, Hagner S, Granger S, Woods G, Morales K. Risk of stroke and conversion to abnormal TCD in children screened with Transcranial doppler (TCD) during the STOP study. Proceedings of the 30th Anniversary Combined Meeting of the National Sickle Cell Disease Program and the Sickle Cell Disease Association of America, Washington DC, September 2002.
29. Adams RJ, Nichols FT, McKie V, McKie K, Milner P, Gammal TE. Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI. Neurology 1988;38:1012-17.
30. Miller ST, Wright E, Abboud M, Berman B, Files B, Scher C, Styles L, Adams RJ. Impact of Chronic Transfusion on Incidence of Pain and Acute Chest Syndrome during the Stroke Prevention Trial in Sickle Cell Anemia (STOP). J Pediatr 2001;139;6:785-789.
31. Wang WC, Morlaes K, Adams R, Brambilla D. Effect of chronic transfusion on growth in children with sickle cell anemia: results of the STOP trial. Proceedings of the 30th Anniversary Combined Meeting of the National Sickle Cell Disease Program and the Sickle Cell Disease Association of America, Washington DC, September 2002.